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SCOPE  

Translational Neuroscience an international journal devoted to the publication of works of wide 
significance, originality and relevance in all areas of the neuroscience. Translational Neuroscience is 
established to provide a closer interaction between basic and clinical neuroscientists to expand our 
understanding of brain structure, function and disease, and translate this knowledge into clinical 
applications and novel therapies of nervous system disorders.  
 
Translational Neuroscience is intended to be the premier source of high quality research. It will report 
novel findings and reviews that are likely to significantly improve thinking and practice in biomedical 
sciences and will cover research findings in all subfields of neuroscience (behavioral, cognitive, 
computational, developmental and regeneration, molecular, neural aging, neuroanatomy, neurobiology, 
neurochemistry, neuroendocrinology, neurogenetics, neuroimmunology, neuropathology, 
neuropharmacology, neurophysiology, methodology, neurotoxicology and systems neuroscience) as well 
as in the closely related fields of neurology, psychiatry and neurosurgery. Therefore, the target audience 
of the journal are both basic and clinical neuroscientists, neurologists, neuropathologists, 
neuroanatomists, neurosurgeons, psychiatrists, psychologists, as well as graduate and postgraduate 
students in medicine and biology.  
 
It is hoped that Translational Neuroscience will also represent an international forum for the dissemination 
of research data aiming at the exchange of ideas thus facilitating the collaboration between researchers 
from different countries. The primary mission of Translational Neuroscience is to assist European 
researchers in communicating their achievements to the global scientific community. Nevertheless, 
contributions from other regions of the world are by all means welcome. The journal is published quarterly 
in English language.  
 
Scope of the journal:  
Behavioral neuroscience  
Brain aging and neurodegeneration  
Cellular, molecular and genomic neuroscience  
Cerebrospinal fluid  
Cognitive neuroscience and neuropsychology  
Computational neuroscience  
Developmental neuroscience  
Evolutionary neuroscience  
Neuroanatomy  
Neurology  
Neurooncology  
Neuroophthalmology  
Neuropathology  
Neuropharmacology and psychopharmacology  
Neurophysiology and sleep medicine  
Neuroprosthetics and neurorobotics  
Neuroradiology and neuroimaging  
Neuroscience methodology  
Neurosurgery  
Psychiatry  
Stem cells and transplantation  
Synaptic neuroscience  
Systems neuroscience  
 
PUBLICATION FORMATS  
 
Translational Neuroscience considers submissions of:  
Research Articles  
Communications and Rapid Communications*,  
Reviews and Mini-Reviews,  
Commentaries  
Case Reports  
Letters to the Editor, Erratum, Corrigendum, Addendum, Retraction Note  
* Rapid Communications are intended to present new information of exceptional novelty and exciting results of 
significant interest to the readers. Authors are asked to provide an explanation in the cover letter why their contribution 
should be handled via a rapid channel.  
 
ELECTRONIC SUBMISSION  
All submissions to Translational Neuroscience must be made via online submission system Editorial 
Manager at editorial.TNSCI@degruyter.com. If you experience difficulties with the manuscript submission 
website, please contact the Editor-in-Chief and Managing Editor Goran Šimić 
(goran.simic@degruyteropen.com).  
Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors 
concur in the submission and are responsible for its content; they must have agreed to its publication and 
have given the corresponding author the authority to act on their behalf in all matters pertaining to 
publication. The corresponding author is responsible for informing the co-authors of the manuscript status 
throughout the submission, review, and production process.  
 
Electronic Formats Allowed  
We accept submission of text, tables and figures as separate files or as a composite file. For your initial 
submission, we recommend you upload your entire manuscript, including tables and figures, as a single 
PDF file. If you are invited to submit a revised manuscript, please provide us with individual files: an 
editable text and publication-quality figures.  
Text files can be submitted in the following formats: MS Word - standard DOCUMENT (.DOC) or RICH 
TEXT FORMAT (.RTF); PDF (not applicable for re-submitted or accepted manuscripts, see below).  
Tables should be submitted as MS Word or PDF (not applicable for re-submitted or accepted manuscripts, 
see below). Please note that a straight Excel file is not an acceptable format.  
Graphics files can be submitted in any of the following graphic formats: EPS; BMP; JPG; TIFF; GIF or 
PDF. Please note that Powerpoint files are not accepted.  
Any articles that have been prepared in LaTeX will be accepted for review, but only in PDF format. Post-
acceptance, text files of the revised manuscript and tables are required for use in the production. Authors 
should clearly indicate the location(s) of tables and figures in the text if these elements are given 
separately or at the end of the manuscript. If this information is not provided to the editorial office, we will 
assume that they should be left at the end of the text.  
 
First-time Submission of Manuscripts  
It is important that authors include a cover letter with their manuscript. Please explain why you consider 
your manuscript to be suitable for publication in the Journal, why your paper will inspire the other 
members of your field, and how will it drive research forward.  
The letter should contain all important details such as:  
your full name (submitted by)  
full title of article and short title  
full list of authors with affiliations  
e-mail of the corresponding author  
contact address, telephone/fax numbers of the corresponding author  
number of attached files, if there is more than one  
status: new, reviewed or accepted (with reference ID if reviewed or accepted)  
 
The cover letter should explicitly state that the manuscript (or one with substantially the same content, by 
any of the authors) has not been previously published in any language anywhere and that it is not under 
simultaneous consideration or in press by another journal. If related work has been submitted, then we 
may require a preprint to be made available. Reviewers will be asked to comment on the overlap between 
the related submissions.  
Manuscripts that have been previously rejected, or withdrawn after being returned for modification, may be 
resubmitted if the major criticisms have been addressed. The cover letter must state that the manuscript is 
a resubmission, and the former manuscript number should be provided.  
To ensure fair and objective decision-making, authors must declare any associations that pose a conflict 
of interest in connection with evaluated manuscripts (see Editorial Policy for details). Authors may suggest 
up to two referees not to use, and in such cases additional justification should be provided in the cover 
letter. Authors are encouraged to recommend up to five reviewers who are not members of their 
institution(s) and have never been associated with them or their laboratory(-ies); please provide contact 
information for suggested reviewers. The Editors reserve the right to select expert reviewers at their 
discretion. The journal uses single-blind peer review process (see Editorial Policy for details). 
 
Submission of Revised Articles  
Resubmitted manuscripts should be accompanied by a letter outlining a point-by-point response to Journal 
Editor's and reviewers' comments and detailing the changes made to the manuscript. A copy of the 
original manuscript should be included for comparison if the Journal Editor requests one. If it is the first 
revision, authors need to return the revised manuscript within 28 days; if it is the second revision, authors 
need to return the revised manuscript within 14 days. Additional time for resubmission must be requested 
in advance. If the above mentioned deadlines are not met, the manuscript will be treated as a new 
submission.  
For resubmitted manuscripts, please provide us with an editable text and publication-quality figures: 
Tables also need to be included within an editable article file or be submitted separately as editable files. 
Supply any figures as separate high-resolution, print-ready digital versions.  
In addition to the editorial remarks, authors are asked to take care that they have prepared the revised 
version according to the Journal's style. Please adopt numbered citation (citation-sequence) style 
referencing.  
 
PREPARATION OF MANUSCRIPTS  
It is essential that contributors prepare their manuscripts according to the instructions and specifications 
presented below.  
 
Reporting Guidelines  
De Gruyter Open supports the development of the reporting of biomedical research. Authors of reviews in 
health sciences are recommended to refer to guidelines of the EQUATOR Network and NLM’s Research 
Reporting Guidelines and Initiatives. The similar reporting checklist for biological and biomedical research 
may be found at MIBBI website. Guidelines are available for a number of study designs, including 
(CONSORT) for randomized controlled trials, (PRISMA) for systematic reviews and meta-analyses, 
(STROBE) for observational studies, (STARD) for diagnostic accuracy studies, (RATS) for qualitative 
studies.  
 
General Rules for Writing  
The work must demonstrate its novelty, importance to the field and its interest to biomedical community in 
general. Conclusions must be justified by the study; please make your argumentation complete and be 
self-critical as you review your drafts.  
The Journal encourages the submission of both substantial full-length bodies of work and shorter 
manuscripts that report novel findings that might be based on a more limited range of experiments. There 
are no specific length restrictions for the overall manuscript or individual sections; however, we urge the 
authors to present and discuss their findings in a concise and accessible manner.  
Use simple, declarative sentences and commonly understood terms; avoid long sentences and idle words. 
Please use active voice while writing your manuscript; e.g. ‘we measured snout-vent length’ rather than 
‘snout-vent length was measured. We recommend that for clarity you use the past tense to narrate 
particular events in the past, including the procedures, observations, and data of the study that you are 
reporting. Use the present tense for your own general conclusions, the conclusions of previous 
researchers, and generally accepted facts. Thus, most of the Abstract, Methods, and Results should be in 
the past tense, and most of the Introduction and some of the Discussion should be in the present tense. 
Editors may make suggestions for how to improve clarity and readability, as well as to strengthen the 
argument.  
 
Organization of the Manuscript  
Articles should be organized into the following sections: 
Title page with: Title (and running title)  
Abstract  
Keywords  
Introduction  
Methods  
Results  
Discussion  
Acknowledgments  
References  
Figure Legends and Table Captions  
Tables  
Figures  
Supplemental data (if applicable)  
 
Each of these elements is detailed below. We draw particular attention to the importance of carefully 
preparing the title, keywords and abstract, as these elements are indicators of the manuscript content in 
bibliographic databases and search engines.  
 
Title  
We suggest the title should be informative, specific to the project, yet concise (75 characters or fewer). 
Please bear in mind that a title that is comprehensible to a broad scientific audience and readers outside 
your field will attract a wider readership. Avoid specialist abbreviations and non-standard acronyms. Titles 
should not be presented in title case (words should not be capitalized). Please also provide a brief 
"running title" of not more than 50 characters.  
 
Authors, Affiliations, Addresses  
De Gruyter Open endorses the International Committee of Medical Journal Editors (ICMJE) definition the 
authorship of the work should collectively fulfill the following four criteria:  
Substantial contributions to the conception or design of the work; or the acquisition, analysis, or 
interpretation of data for the work;  
Drafting the work or revising it critically for important intellectual content;  
Final approval of the version to be published;  
Agreement to be accountable for all aspects of the work in ensuring that questions related to the 
accuracy or integrity of any part of the work are appropriately investigated and resolved.  
 
Those who do not meet the all four criteria should be acknowledged (see Acknowledgments). It is the sole 
responsibility of contributors to determine the authors of the manuscript submitted to the journal.  
In the cover letter, provide the first names (or initials - if used), middle names (or initials - if used), and 
surnames for all authors. Affiliations should include:  
Department  
University or organization  
City  
Postal code  
State/province (if applicable)  
Country  
 
One of the authors should be designated as the corresponding author to whom inquiries regarding the 
paper should be directed. It is the corresponding author's responsibility to ensure that the author list and 
the summary of the author contributions to the study are accurate and complete. Place an asterisk after 
the name of the corresponding author and provide us with a valid e-mail address. Footnotes can be used 
to present additional information (for example: permanent, adequate, present postal addresses). If the 
article has been submitted on behalf of a consortium, all consortium members and affiliations should be 
listed after the Acknowledgments.  
 
Addition or Removal of Authors  
The authors’ request for addition or removal of an author should be properly justified. Please note that a 
change in authorship (order of listing, addition or deletion of a name, or corresponding author designation) 
after submission of the manuscript will be implemented only after receipt of signed statements of 
agreement from all parties involved (all listed authors and the author to be removed or added). 
 
Abstract and Image accompanying abstract  
The abstract should not exceed 200 words. The abstract should give a summary of the content of the 
paper and is usually conceptually divided into: Background, Methodology, Principal Findings/Results, and 
Conclusions/Significance. Mention the techniques used without going into methodological detail and 
summarize briefly the most important items of the paper. Please do not include any citations or references 
to tables or figures, and avoid specialist abbreviations and symbols. Because the abstract will be 
published separately by abstracting services, it must be complete and understandable without reference to 
the text.  
Authors may provide a striking image to accompany their article, if one is available. If the image (photo, 
graph, scheme) is judged by the editors to be suitable for publication, it may be featured on the web to 
highlight the paper online. It is preferable, but not essential, that these should be related strictly to the 
subject reported in the manuscript. The image could originate from the experimental findings reported in 
the manuscript but does not have to constitute a part of the original work and need not be reprinted in the 
article. Images must be original and should be submitted as separate files.  
 
Keywords  
List keywords for the work presented (maximum of 10), separated by commas. We suggest that keywords 
do not replicate those used in the title. Authors should use keywords that are specific and emphasize what 
is essential in the presented study.  
 
Introduction  
The introduction should put the focus of the manuscript into a broader context and should supply sufficient 
background information to allow the reader to understand and evaluate the results without referring to 
previous publications on the topic. As you compose the introduction, think of readers who are not experts 
in this field. Include a brief review of the key literature - use only those references required to provide the 
most salient background rather than an exhaustive review of the topic. Relevant controversies or 
disagreements in the field should be mentioned so that a non-expert reader can delve into these issues 
further. The introduction should conclude with a brief statement of the rationale for the study, the 
hypothesis that was addressed or the overall purpose of the experiments reported, and should provide a 
comment about whether that aim was achieved.  
 
Methods  
This section should include sufficient technical information to enable the experiments to be reproduced. 
Protocols for new methods or significant modifications to existing methods should be included, while 
previously published or well-established protocols should only be referenced. Describe new methods 
completely and give sources of unusual chemicals, equipment, strains etc. Studies presented should 
comply with our recommendations for distribution of materials and data (see below). In theoretical papers 
comprising the computational analyses, technical details (methods, models applied or newly developed) 
should be provided to enable the readers to reproduce the calculations.  
 
Results  
This section should provide statistical analyses of all of the experiments that are required to support the 
conclusions of the paper. Reserve extensive interpretation of the results for the Discussion section. Details 
of experiments that are peripheral to the main thrust of the article and that detract from the focus of the 
article should not be included. Present the results as concisely as possible in text, table(s), or figure(s) 
(see below). Avoid extensive use of graphs to present data that might be more concisely presented in the 
text or tables. Graphs illustrating methods commonly used need not be shown except in unusual 
circumstances. Limit photographs to those that are absolutely necessary to show the experimental 
findings. Number figures and tables in the order in which they are cited in the text, and be sure to cite all 
figures and tables. Styles and fonts should match those in the main body of the article. Large datasets, 
including raw data, should be submitted as supporting files. The section may be divided into subsections, 
each with a concise subheading.  
 
Discussion  
The Discussion should provide an interpretation of the results in relation to previously published work and 
to the experimental system used. It should not contain extensive repetition of the Results or reiteration of 
the Introduction. This section should spell out the major conclusions of the work along with some 
explanation or speculation on the significance of these conclusions. The discussion should be concise and 
tightly argued.  
 
Acknowledgments  
This section should describe sources of funding that have supported the work. Please also describe the 
role of the study sponsor(s), if any, in study design; collection, analysis, and interpretation of data; writing 
of the paper; and decision to submit it for publication. Recognition of personal assistance should be given 
as a separate paragraph: people who contributed to the work, but do not fit the criteria for authors should 
be listed along with their contributions. You must ensure that anyone named in the acknowledgments 
agrees to being so named. Following the Recommendations for the Conduct, Reporting, Editing, and 
Publication of Scholarly Work in Medical Journals from the International Committee of Medical Journal 
Editors (ICMJE) editors are advised to require that the corresponding author obtain written permission to 
be acknowledged from all acknowledged individuals.  
In this section authors should explicitly reveal all potential financial, personal or professional conflicts of 
interest. Authors should also explicitly state if there is no such conflict regarding the publication of the 
article. Authors are suggested to fill in the ICMJE Conflicts of Interest Form and send the electronic 
version to the Journal Editor.  
 
References  
Because all references will be linked electronically to the papers they cite, proper formatting of the 
references is crucial. A complete reference should give the reader enough information to find the relevant 
article. Please pay particular attention to spelling, capitalization and punctuation.  
References to unpublished or submitted work, unpublished conference presentations, personal 
communications, patent applications and patents pending, computer software, databases, and websites 
should be referred to as such only in the body of the text. These should be kept to a minimum. The 
examples are as follows:  
(J. Smith, unpublished data),  
(J. Smith and P. Brown, submitted for publication),  
(J. Smith, personal communication),  
(J. Smith and P. Brown, presented at the 4th Symposium on Food Microbiology, Overton,  
IL, 13 - 15 June 1989),  
(J. C. Odell, April 1970, Process for batch culturing, U.S. patent 484,363,770),  
(J. Smith, 20 June 1999, Australian Patent Office),  
… from the GenBank database (http://www.ncbi.nlm.nih.gov/Genbank/index.html),  
... using ABC software (version 2.2; Department of Microbiology, State University, http://www.stu.micro ),  
Published or accepted ('in press') manuscripts, books and book chapters, and theses should be included 
in the reference list. References to published meeting abstracts should be kept to a minimum.  
For all references, list the first six authors; add "et al." if there are additional authors. Standard 
abbreviations of journal names according to the style used for MEDLINE should be used.  
Please use the following style for the reference list:  
 
Published Papers  
Kulig P., Zabel B.A., Dubin G., Allen S.J., Ohyama T., Potempa J., et al., Staphylococcus aureus-derived 
staphopain B, a potent cysteine protease activator of plasma chemerin, J. Immunol., 2007, 178, 3713-
3720  
 
Accepted Papers  
Kulig P., Zabel B.A., Dubin G., Allen S.J., Ohyama T., Potempa J., et al., Staphylococcus aureus-derived 
staphopain B, a potent cysteine protease activator of plasma chemerin, J. Immunol., (in press), DOI: 
12.3412/01  
 
Electronic Journal Articles  
Dionne M.S., Schneider D.S., Screening the immune system, Genome Biol., 2002, 
http://genomebiology.com/2002/3/4/reviews/1010  
 
Books and book chapters  
Sambrook J., Russell D.W., Molecular cloning - a laboratory manual, 3rd ed., Cold Spring Harbor 
Laboratory Press, Cold Spring Harbor, 2001  
 
Theses  
Agutter A.J., Analysis of sigma factors in S. aureus, PhD thesis, Edinburgh University, Edinburgh, UK, 
1995  
 
Conference proceedings  
Smith J., Brown P., Reference style guide, In: M. Scott (Ed.), Proceedings of Biochemical Society 
Conference (11-13 July 2007, Warszawa, Poland), Versita Warsaw, 2007, 1335-1791  
 
Newspaper articles  
Sherwin A., The post-genomic era, The Times, 13 July 2007, 1-2 
M. Dzierzanowski, Horyzonty, Wprost, 8 July 2007, 18 (in Polish)  
 
References should be listed and numbered in the order that they appear in the text. In the text, citations 
should be indicated by the reference number in brackets [1]. Multiple citations within a single set of 
brackets should be separated by commas [1,2]. Where there are more than three sequential citations, 
they should be given as a range [1-4]. References in figure captions and tables should be listed after 
references in the text.  
 
Figures and Figure Legends  
Authors may use photographs, schemes, diagrams, line graphs and bar charts to illustrate their findings. 
Figures included with online submissions should be suitable for onscreen viewing and desktop printing. 
High resolution images should be provided on request or on manuscript acceptance. The figures and their 
lettering should be clear and easy to read, e.g., no labels should be too large or too small. 
Photomicrographs should include a scaled bar and indicate the size. We remind authors that it is not 
acceptable scientific conduct to modify any separate element within an image (adjustments of the entire 
image in brightness, contrast and color balance are justified only if they do not misrepresent the original, 
observed data). Composite figures composed of grouped images such as insets from different fields or 
separate parts of gels must be explained in the figure legend and differentiated by use of dividing lines or 
other means to make composites unambiguous. Figures should be numbered consecutively using Arabic 
numerals and referred to in the text by number. Figure legends should follow the main text, each on a 
separate page. Each figure legend should have a concise title and should provide enough information so 
that the figure is understandable without frequent reference to the text. It should inform the reader of key 
aspects of the figure, but the figure should also be discussed in the text. The legend should be succinct, 
while still explaining all symbols and abbreviations. Avoid lengthy descriptions of methods. 
  
Tables and Table Captions  
Tables must include enough information to warrant table format and should be used only where 
information cannot be presented in the text. Tables should be typed as text, using either 'tabs' or a table 
editor for layout; please do not use graphics software to create tables. Tables occupying more than one 
printed page should be avoided, if possible; larger tables can be published as an appendix. Do not use 
picture elements, text boxes, tabs, or returns in tables. Tables that contain artwork, chemical structures, or 
shading must be submitted as illustrations. Tables should be numbered consecutively using Arabic 
numerals and referred to in the text by number. Table legends should follow the main text, each on a 
separate page. Each table should have an explanatory caption which should be as concise as possible. 
The headings should be sufficiently clear so that the meaning of the data is understandable without 
reference to the text. Footnotes can be used to explain abbreviations but should not include detailed 
descriptions of the experiment. Citations should be indicated using the same style as outlined above.  
 
Equations  
In-line equations should be typed as text. The use of graphics programs and 'equation editors' should be 
avoided.  
 
Abbreviations  
Please keep abbreviations to a minimum. In addition to abbreviations for Systeme International d'Unités 
(SI) units of measurement, other common units (e.g., bp, kb, and Da), and chemical symbols for the 
elements, the following should be used without definition: DNA; cDNA; RNA; cRNA; RNase; DNase; 
rRNA; mRNA; tRNA; AMP, ADP, ATP, dAMP, ddATP, GTP, etc.; ATPase, dGTPase, etc.; NAD; NAD+; 
NADH; NADP; NADPH; NADP+; poly(A), poly(dT), etc.; oligo(dT), etc.; UV; PFU; CFU; MIC; Tris; DEAE; 
EDTA; EGTA; HEPES; PCR; and AIDS. Abbreviations for cell lines (e.g., HeLa) as well as viruses (e.g., 
HIV-1, JC virus, BK virus) also need not be defined. Non-standard abbreviations should not be used 
unless they appear at least three times in the text. List all non-standard abbreviations, acronyms and 
symbols in alphabetical order, along with their expanded form, at the end of the text. Define them as well 
upon first use in the text.  
 
Supplemental Material  
We encourage authors to submit essential supplementary files that additionally support the authors' 
conclusions along with their manuscripts (the principal conclusions should be fully supported without 
referral to the supplemental material). Supplemental material will always remain associated with its article 
and is not subject to any modifications after publication. The decision to publish the material with the 
article if it is accepted will be made by the Editor. Supporting files of no more than 10 MB in may be 
submitted in a variety of formats, but should be publication-ready, as these files will be published exactly 
as supplied. Material must be restricted to large or complex data sets or results that cannot be readily 
displayed because of space or technical limitations. Material that has been published previously is not 
acceptable for posting as supplemental material.  
Supporting files should fall into one of the following categories:  
Dataset  
Additional Figure or Table  
Text  
Protocol  
Multimedia - Audio/Video/Animations (AVI, MPEG, WAV, Quicktime, animated GIF or Flash)  
 
If the software required for users to view/use the supplemental material is not embedded in the file, you 
are urged to use shareware or generally available/easily accessible programs. To prevent any 
misunderstandings, we request that authors submit a text file (instruction.txt) containing a brief instruction 
on how to use the files supplied. All supporting information should be referred to in the manuscript, with 
titles (and, if desired, legends) for all files listed under the heading 'Supporting Information'.  
Nomenclature  
We strongly recommend the use of correct and established nomenclature wherever possible. Always 
report numerical data (length, weight, and volume) in the appropriate SI units. Please refer to International 
Union of Pure and Applied Chemistry (IUPAC) recommendations available for standard metric units. For 
these units and for molarity, use the prefixes (p= 10-12, n = 10-9, μ= 10-6, m = 10-3, c = 10-2, d = 10-1, h 
= 102, k = 103, M = 106, G = 109, etc.). Use μg/ml or μg/g in place of the ambiguous ppm. When fractions 
are used to express units, it is preferable to use whole units, such as 'g' or 'min', in the denominator 
instead of fractional or multiple units, such as μg or 10 min (for example 'pmol/min' is preferable to 
'nmol/10 min', and 'μmol/g' is preferable to 'nmol/μg'). It is also preferable that an unambiguous form such 
as exponential notation be used; for example, 'μmol g-1 min-1' is preferable to 'μmol/g/min'. Units of 
temperature are presented in degrees centigrade (i.e. 37°C).  
The recognized authority for the names of chemical compounds is Chemical Abstracts. For guidelines to 
the use of biochemical terminology, consult Biochemical Nomenclature and Related Documents. Do not 
express molecular weight in Daltons: molecular weight is a unitless ratio; molecular mass is expressed in 
daltons. For enzymes, use the recommended name assigned by the Nomenclature Committee of the 
International Union of Biochemistry. Use the EC number when one has been assigned.  
For genes, proteins, strains, clones etc. use the recommended name by consulting the appropriate 
genetic nomenclature database. Genes, mutations, genotypes, and alleles should be indicated in italics; 
protein products of the loci are not italicized. It is sometimes advisable to indicate the synonyms for the 
gene the first time it appears in the text. Gene prefixes such as those used for oncogenes or cellular 
localization should be shown in roman: v-fes, c-MYC, etc.  
 
Formatting and Typesetting  
All pages must be numbered consecutively. The whole text (including legends, footnotes, and references) 
should be formatted double-spaced with no hyphenation and automatic word-wrap (no hard returns within 
paragraphs). Please type your text consistently, e.g. take care to distinguish between '1' (one), 'I' (capital I) 
and 'l' (lower-case L) and '0' (zero) and 'O' (capital O), etc. Manuscript pages should have line numbers. 
The font size should be no smaller than 12 points.  
Footnotes and endnotes should be avoided. Allowable footnotes/endnotes may include: the designation of 
the corresponding author of the paper, the current address of an author (if different from that shown in the 
affiliation), abbreviations and acronyms.  
Do not create symbols as graphics or use special fonts that are external to your word processing program; 
use the "insert symbol" function. Indicate paragraph lead-ins in bold type and italicize any words that 
should appear in italics. All Latin names should be italicized, including species names and common 
structures such as: et al.; in vivo; in vitro; ex vivo; in silico; etc.; de novo; a priori; ab initio; vice versa; in 
situ; ad hoc; sensu stricto; i.e.; ca. /circa; n.b. /nota bene. Decimal multiples or submultiples of units are 
indicated by the use of prefixes. There should be a single space between most units and the 
corresponding number; the only exceptions are: 1%, 1‰, 1°C, 1°, 1', 1".  
 
DISTRIBUTION OF MATERIALS AND DATA  
The publication of an article in the journal is subject to the understanding that authors will make all data 
and associated protocols available to readers on request. The Methods section should include details of 
how materials and information may be obtained. In cases of dispute, authors may be required to make any 
primary data available to the Journal Editor.  
The authors are encouraged to distribute freely any materials used in experiments (cells, strains, clones, 
antibodies etc.) to academic researchers for their own use. Authors are expected to use established public 
repositories wherever possible. All newly reported data including datasets, images, and information 
(Nucleotide and Amino Acid Sequences, Structural Determinations, Microarray Data, Genomic and 
Proteomic studies, Taxonomy etc.) should be deposited in public resources and must be accessible 
without restriction from the date of publication. Please provide the relevant entry name, accession number 
or identification code in the Methods section. Please note that an author's web site is not acceptable for 
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